GlassScriptPhysician profile
Robert A Batler
NPI 1457375685
$5,807.81
in general payments reported to CMS, 2019-2025
44 companies · $885 in 2025
The $885 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $83.83 · 2021: $140 · 2022: $564 · 2023: $1,235 · 2024: $1,901 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,292 · Travel and Lodging: $708 · Education: $19.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.22 |
| Travel and Lodging | $708.06 |
| Education | $19.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $809.07 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $547.85 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $406.80 | 2019-2024 | Provenge |
| Pfizer INC. | $406.49 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $333.40 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $323.34 | 2019-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $220.04 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $195.40 | 2019-2023 | Myrbetriq, Xtandi |
| Abbvie INC. | $195.07 | 2019-2025 | Botox, Lupron Depot |
| Antares Pharma, INC. | $190.02 | 2019-2024 | Xyosted |
| Endo Pharmaceuticals INC. | $183.43 | 2019-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $180.55 | 2019-2025 | Ams 700, Advance Xp, Rezum Generator |
| Accord Healthcare, INC. | $165.63 | 2023-2025 | |
| Procept Biorobotics Corporation | $149.12 | 2023 | Aquabeam Robotic System |
| Amgen INC. | $113.53 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Batler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.